Diana Miglioretti
Has grant
Professor and Division Chief of Biostatistics
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Diana Miglioretti is a Professor and Division Chief of Biostatistics at the University of California Davis, USA. Her research areas include the impact of mammography on breast cancer detection, disparities in diagnostic services, and the influence of breast density on cancer risk. Recent articles highlight her work on the performance of supplemental screening and the assessment of cancer detection rates in mammography.
Recent Grants
Grant: Close
Comparative Effectiveness of Breast Cancer Screening and Diagnostic Evaluation by Extent of Breast Density
Open Date: 2016-01-01
Close Date: 2021-03-31
Grant: Close
Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging
Open Date: 2015-03-01
Close Date: 2020-05-31
Grant: Close
Risk-based Breast Cancer Screening and Surveillance in Community Practice
Open Date: 2011-09-27
Close Date: 2022-05-31
Grant: Close
Comparative effectiveness of breast imaging strategies in community practice
Open Date: 2009-09-30
Close Date: 2011-08-31
Grant: Close
Comparative effectiveness of breast imaging strategies in community practice
Open Date: 2009-09-30
Close Date: 2012-08-31
Articles (19)
Year:
2025
Year:
2025
Year:
2025
Background Annual surveillance mammography is recommended for women with a personal history of breast cancer. Risk prediction models that estimate mammography failures such as interval second breast cancers could help to tailor surveillance imaging regimens to women’s individual risk profiles. Methods In a cohort of women with a history of breast cancer receiving surveillance mammography in the Breast Cancer Surveillance Consortium in 1996-2019, we used Least Absolute Shrinkage and Selection Operator (LASSO)-penalized regression to estimate the probability of an interval second cancer (invasive cancer or ductal carcinoma in situ) in the 1 year after a negative surveillance mammogram. Based on predicted risks from this one-year risk model, we generated cumulative risks of an interval second cancer for the five-year period after each mammogram. Model performance was evaluated using cross-validation in the overall cohort and within race and ethnicity strata. Results In 173 290 surveillance mammograms, we observed 496 interval cancers. One-year risk models were well-calibrated (expected/observed ratio = 1.00) with good accuracy (area under the receiver operating characteristic curve = 0.64). Model performance was similar across race and ethnicity groups. The median five-year cumulative risk was 1.20% (interquartile range 0.93%-1.63%). Median five-year risks were highest in women who were under age 40 or pre- or perimenopausal at diagnosis and those with estrogen receptor-negative primary breast cancers. Conclusions Our risk model identified women at high risk of interval second breast cancers who may benefit from additional surveillance imaging modalities. Risk models should be evaluated to determine if risk-guided supplemental surveillance imaging improves early detection and decreases surveillance failures.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (11)
Etta Pisano
Chief Research Officer
-
Louise Henderson
Professor
University of North Carolina
Sarah Nyante
University of North Carolina at Chapel Hill
Karla Kerlikowske
University of California
Janie M Lee
-
William Hsu
Professor
University of California, Los Angeles
Laura Esserman
University of California
Rebecca Hubbard
Professor, Clinician-Educator
University of Pennsylvania
Katherine Tossas
Virginia Commonwealth University
Diana Buist
Affiliate Professor
University of Washington
Shuai Chen
Assistant Professor
University of California, Davis
Make your next move.
Prepare your application
Review drafts before you send them.